Robert M Scarborough, Deceased

Title: Robert M Scarborough: A Legacy in Pharmaceutical Innovation

Introduction

Robert M Scarborough was a notable inventor in the field of pharmaceuticals, recognized for his contributions to the development of novel compounds aimed at treating coagulation disorders. His work has had a lasting impact on the medical community, particularly in the area of factor Xa inhibitors.

Latest Patents

Scarborough held a patent for "Benzamides and related inhibitors of factor Xa." This patent describes novel benzamide compounds, including their pharmaceutically acceptable isomers, salts, hydrates, solvates, and prodrug derivatives that exhibit activity against mammalian factor Xa. The compounds and compositions outlined in the patent are useful both in vitro and in vivo for preventing or treating coagulation disorders.

Career Highlights

Throughout his career, Scarborough was associated with Millennium Pharmaceuticals Limited, where he contributed significantly to pharmaceutical research and development. His innovative approach to drug design has paved the way for advancements in therapeutic options for patients suffering from coagulation issues.

Collaborations

Scarborough collaborated with esteemed colleagues, including Bing-Yan Zhu and Wenrong Huang, who shared his vision for advancing pharmaceutical science. Their collective efforts have contributed to the success of various projects within the industry.

Conclusion

Robert M Scarborough's legacy as an inventor and researcher continues to influence the field of pharmaceuticals. His work on factor Xa inhibitors remains a testament to his dedication to improving patient care through innovative solutions.